info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Automated Cell Counters Market Share

ID: MRFR//10561-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

The Automated Cell Counters market, a pivotal segment within the broader life sciences industry, is witnessing intense competition as companies strive to establish and expand their market share. In this dynamic landscape, market share positioning strategies play a crucial role in determining the success and sustainability of businesses operating in this sector. Companies in the Automated Cell Counters market employ various strategies to gain a competitive edge and enhance their market presence.

One prevalent strategy involves product differentiation, where companies focus on offering unique features and capabilities in their automated cell counting devices. This approach aims to address specific needs and preferences of end-users, such as researchers and healthcare professionals. By providing innovative solutions with advanced functionalities, companies can attract a niche market segment and distinguish themselves from competitors. For instance, some automated cell counters may incorporate advanced imaging technologies or user-friendly interfaces to simplify the cell counting process, thus gaining favor among users seeking efficiency and precision.

Another key market share positioning strategy is pricing. Companies often adopt different pricing models to target specific customer segments based on their budget constraints and preferences. Some businesses may opt for a premium pricing strategy, positioning their automated cell counters as high-end, sophisticated instruments with advanced features. This appeals to customers who prioritize quality and are willing to pay a premium for top-notch performance. On the other hand, companies pursuing a cost leadership strategy may focus on providing cost-effective solutions without compromising on essential functionalities, capturing the attention of budget-conscious customers.

Strategic partnerships and collaborations also emerge as significant drivers in the market share positioning of Automated Cell Counters. Companies may enter into collaborations with research institutions, healthcare providers, or industry leaders to expand their market reach and enhance their credibility. By aligning with key stakeholders, businesses can leverage their partners' expertise and resources, gaining a competitive advantage in terms of market knowledge, distribution channels, and customer relationships.

Moreover, an emphasis on market segmentation allows companies to tailor their products to specific customer needs. Understanding the diverse requirements of different end-users, such as laboratories, academic institutions, or pharmaceutical companies, enables businesses to develop targeted marketing strategies. By customizing their offerings, companies can effectively address the unique challenges faced by each segment, thus strengthening their market position.

Customer-centric approaches, such as after-sales support and service, also contribute significantly to market share positioning. Companies that prioritize customer satisfaction by offering comprehensive training programs, prompt technical assistance, and regular maintenance services can build strong relationships with their clients. A satisfied customer base is likely to be loyal and may act as brand advocates, positively impacting the company's market share over the long term.

Covered Aspects:

Report Attribute/Metric Details
Growth Rate 5.80% (2023-2032)

Global Automated Cell Counters Market Overview


Automated Cell Counters Market Size was valued at USD 6.1 Billion in 2022. The Automated cell counters market industry is projected to grow from USD 6.4 Billion in 2023 to USD 10.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032).Rising incidence of chronic diseases, increased research activities, point-of-care testing (POCT), growing awareness of preventive healthcare, emerging markets, COVID-19 pandemic, customization and integration, are the key market drivers enhancing the market growth.


Automated Cell Counters Market Overview


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Automated Cell Counters Market Trends



  • Rising incidence of chronic diseases is driving the market growth


One of the main factors propelling the market for automated cell counts is the rise in the prevalence of chronic diseases. Cancer, diabetes, cardiovascular disease, autoimmune disorders, and respiratory illnesses are examples of chronic diseases, which are distinguished by their protracted nature and frequently disabling effects. The need for precise, effective, and quick diagnostic technologies, like automated cell counters, has grown dramatically as these illnesses become more widespread worldwide.


To monitor illness progression, therapy effectiveness, and patient health in general for chronic diseases, regular monitoring is frequently necessary. By delivering quick and accurate assessments of blood cell counts, hemoglobin levels, and other hematological parameters, automated cell counters serve a crucial role in this respect. This improves the quality of care for patients with chronic diseases by assisting healthcare practitioners in making knowledgeable decisions and changing treatment programs as necessary.


Improved patient outcomes and less strain on healthcare systems may result from early diagnosis of chronic diseases. Automated cell counters make it possible to detect irregular blood cell counts early on, which can be a sign of more serious health problems. Early disease detection enables prompt treatment, which may stop or delay the progression of the disease and ultimately lower treatment expenses.


The COVID-19 pandemic highlighted the value of diagnostic methods in handling medical emergencies. Despite not being a chronic condition, COVID-19 highlighted the crucial role that automated cell counters play in evaluating patients' immunological responses, tracking the severity of the disease, and supporting therapeutic decision-making. Greater investments and demand for diagnostic technology have resulted from this greater knowledge of these tools. Thus, driving the automated cell counters market revenue.


Automated Cell Counters Market Segment Insights


Automated cell counters Product Type Insights


The automated cell counters market segmentation, based on product type, includes fluorescence image-based cell counter, flow cytometer and coulter counter. The coulter counter segment dominated the market in 2022. Coulter counters are recognized for their exceptional accuracy and precision when it comes to cell counting and sizing. They use the electrical impedance theory to calculate the volume of each cell as it passes through a microscopic hole. This accuracy is crucial since numerous applications, including clinical diagnosis and research, call for precise cell measurements.


Automated cell counters Application Insights


The automated cell counters market segmentation, based on Application, includes blood cells, cell lines, microbial cells and others. The blood cells segment dominated the market in 2022. Anemia, leukemia, lymphoma, and thrombocytopenia are among the hematological conditions that are on the rise worldwide. Blood cell counts are frequently necessary for these disorders to track the development of the disease, assess the effectiveness of treatment, and identify relapses. Automated cell counts are essential for controlling hematological illnesses because they produce accurate data quickly.


Figure 1: Automated Cell Counters Market, by Application, 2022 & 2032 (USD Billion)


Automated Cell Counters Market, by Application, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Automated cell counters End-use Insights


The automated cell counters market segmentation, based on end-use, includes pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, research institutes and others. The hospitals category generated the most income in 2022. This is because automated cell counters are in high demand in clinical laboratories for blood analysis. Blood cells must be counted and analyzed by automated cell counters in order to diagnose and treat a range of blood illnesses.


Automated cell counters Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Automated Cell Counters Market dominated this market in 2022 (45.80%). North America is the world leader in biomedical research and development. The region is home to a large number of pharmaceutical enterprises, biotech companies, and academic research centers for drug discovery, clinical trials, and fundamental research. This ongoing research activity fuels the demand for better cell counting machinery. Further, the U.S. Automated cell counters market held the largest market share, and the Canada Automated cell counters market was the fastest growing market in the North America region.


Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022 (USD Billion)


AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Automated cell counters market accounts for the second-largest market share. Public health projects focused at disease prevention and early detection are frequently started by European governments and healthcare institutions. These initiatives can include screenings that use computerized cell counters to find those at risk for different illnesses. Further, the German Automated cell counters market held the largest market share, and the UK Automated cell counters market was the fastest growing market in the European region.


The Asia-Pacific Automated Cell Counters Market is expected to grow at the fastest CAGR from 2023 to 2032. Both densely populated urban areas and isolated rural areas make up Asia Pacific's enormous and diversified population. In order to meet a wide range of medical demands, the sheer size of the population generates a significant demand for healthcare services, including diagnostic equipment like automated cell counters. Moreover, China’s automated cell counters market held the largest market share, and the Indian Automated cell counters market was the fastest growing market in the Asia-Pacific region.


Automated Cell Counters Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the automated cell counters market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, automated cell counters industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the automated cell counters industry to benefit clients and increase the market sector. In recent years, the automated cell counters industry has offered some of the most significant advantages to medicine. Major players in the Automated cell counters market, including Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others, are attempting to increase market demand by investing in research and development operations.


Thermo Fisher Scientific Inc. (Thermo Fisher) delivers medical equipment, analytical instruments, reagents and consumables, software, and services to satisfy the demands of challenging analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular biology, synthetic biology, and flow cytometry. Mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research equipment are just a few of the many products that the company sells. The company offers services to companies in the environmental, industrial quality, and process control sectors, as well as to academic and research institutes, governmental organizations, pharmaceutical and biotech companies, clinical diagnostic laboratories, and environmental companies. It provides its products and services through its direct sales force, online sales, and third-party distributors across the Americas, Asia-Pacific, and Europe. The headquarters of Thermo Fisher are located in Waltham, Massachusetts, in the US.


Abbott Laboratories (Abbott) discovers, develops, manufactures, and sells a wide range of healthcare products, including branded generic drugs, diagnostic devices, and infant, child, and adult nutritional supplements. Additionally, the company sells a variety of medical devices, including those for heart failure, neuromodulation, electrophysiology, rhythm management, and vascular and structural cardiac devices. Additionally, the company offers nutritional products, minerals, and dietary supplements. It has production facilities all around the world and R&D facilities in the US, China, Colombia, India, Singapore, Spain, and the UK. Africa, the Middle East, Latin America, North America, and the Asia-Pacific area are among the regions where the firm sells its products. Abbott is based in Abbott Park, Illinois, a city in the US.


Key companies in the automated cell counters market include



  • Eppendorf

  • Thermo Fischer Scientific

  • Countstar, Inc.

  • Bio-Rad Laboratories, Inc.

  • F. Hoffmann-La Roche Ltd

  • Chemometec A/S

  • ALIGNEDGENETICS

  • Beckman Coulter, Inc. (Danaher)

  • Nanoentek

  • Olympus Corporation

  • MERCK KGaA

  • Sysmex Corporation

  • Agilent Technologies, Inc.

  • Abbott

  • Nexcelom Bioscience LLC


Automated cell counters Industry Developments


March 2022:The complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests are included in Mindray's new BC-700 Series of hematology analyzers.


February 2022:Abacus dx and Luminex have formed a new agreement for the Guava line of flow cytometry tools and supplies. As part of the agreement, Abacus dx will sell Luminex's Guava line of flow cytometry tools and supplies.


June 2022:The FAD approved the Sysmex Corporation's XN-10 hematological analyzer with blood bank mode. A highly developed automated hematology analyzer called the XN-10 is used to count white blood cells.


Automated Cell Counters Market Segmentation


Automated Cell Counters Product Type Outlook



  • Fluorescence image-based cell counter

  • Flow cytometer

  • Coulter counter


Automated Cell Counters Application Outlook

  • Blood Cells

  • Cell lines

  • Microbial cells

  • Others


Automated Cell Counters End-use Outlook



  • Pharmaceutical & biotechnology companies

  • Hospitals

  • Diagnostic laboratories

  • Research institutes

  • Others


Automated Cell Counters Regional Outlook



  • North America

    • U.S.

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.